Tag: Ravulizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ravulizumab

AstraZeneca to Acquire Alexion, Accelerating the Company's Strategic and Financial Development

Added to Collection on: 2020-12-12 12:45:00

Tags for this article:

Companies
Life Sciences
Mergers and acquisitions
Orphan drugs
AstraZeneca
Alexion Pharmaceuticals
Centerview Partners
Eculizumab
Evercore
Goldman Sachs
Ravulizumab
Ludwig N. Hantson
Ludwig Hantson
Boston
Alexion Pharmaceuticals Inc.
United States
United Kingdom

Click the tags to see associated articles and topics

View Article Details
AstraZeneca to acquire Alexion, accelerating the company's strategic and financial development

Added to Collection on: 2020-12-13 15:56:15

Tags for this article:

Orphan drugs
Drugs
Companies
Health care
AstraZeneca
Södertälje Municipality
Eculizumab
Ravulizumab
Alexion Pharmaceuticals
Alexion

Click the tags to see associated articles and topics

View Article Details
AstraZeneca to acquire Alexion, enhancing presence in immunology

Added to Collection on: 2020-12-14 15:45:00

Tags for this article:

Medical specialties
Clinical medicine
Health care
Orphan drugs
Eculizumab
Immunosuppressants
AstraZeneca
Ravulizumab
Immunology
Monoclonal antibody
Neuromyelitis optica
Alexion Pharmaceuticals
Alexion

Click the tags to see associated articles and topics

View Article Details
FDA Clears Ravulizumab for Neuromyelitis Optica Spectrum Disorder - Medscape

Added to Collection on: 2024-03-25 20:42:21

Tags for this article:

Rare diseases
Orphan drugs
Monoclonal antibodies
Blood disorders
Acquired hemolytic anemia
Neuromyelitis optica spectrum disorder
Atypical hemolytic uremic syndrome
Eculizumab
Ravulizumab
Hemolytic–uremic syndrome
Multiple sclerosis
Paroxysmal nocturnal hemoglobinuria

Click the tags to see associated articles and topics

View Article Details
FDA approves Ultomiris for neuromyelitis optica spectrum disorder - Healio

Added to Collection on: 2024-03-26 22:13:13

Tags for this article:

Monoclonal antibodies
Orphan drugs
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Ravulizumab
Eculizumab
Biopharmaceutical
Interleukin 6
Saif AlRyalat
Osama Al Deyabat
Andrew G. Lee

Click the tags to see associated articles and topics

View Article Details
Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG

Added to Collection on: 2024-04-15 20:56:51

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Autoimmune diseases
Eculizumab
Myasthenia gravis
Rare diseases
Ravulizumab
Apheresis
Atypical hemolytic uremic syndrome

Click the tags to see associated articles and topics

View Article Details
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies

Added to Collection on: 2024-04-18 20:19:56

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Acquired hemolytic anemia
Health economics
Paroxysmal nocturnal hemoglobinuria
Pegcetacoplan
Eculizumab
Ravulizumab
PNH
Quality-adjusted life year
Cost–utility analysis

Click the tags to see associated articles and topics

View Article Details
US FDA approves Roche's drug for a chronic blood disorder - The Indian Express

Added to Collection on: 2024-06-21 22:55:23

Tags for this article:

Monoclonal antibodies
Blood disorders
Orphan drugs
Rare diseases
Acquired hemolytic anemia
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Atypical hemolytic uremic syndrome
Crovalimab
Ravulizumab
Hemolytic–uremic syndrome
Hemolysis
Roche Pharma
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Roche's PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give ...

Added to Collection on: 2024-09-02 21:31:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Pegcetacoplan
Crovalimab
Eculizumab
Iptacopan
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Danicopan
United States
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) - GlobeNewswire

Added to Collection on: 2024-12-08 00:03:59

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Hematology
Rare diseases
Ravulizumab
Paroxysmal nocturnal hemoglobinuria
Lactate dehydrogenase
Hemolysis
Anemia
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Book a Demo